Last reviewed · How we verify
Lauric Acid — Competitive Intelligence Brief
marketed
dodecanoic acid
G-protein coupled receptor 84, Free fatty acid receptor 1, Peroxisome proliferator-activated receptor delta
Metabolic
Live · refreshed every 30 min
Target snapshot
Lauric Acid (dodecanoic acid).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lauric Acid TARGET | dodecanoic acid | marketed | dodecanoic acid | G-protein coupled receptor 84, Free fatty acid receptor 1, Peroxisome proliferator-activated receptor delta |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (dodecanoic acid class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lauric Acid CI watch — RSS
- Lauric Acid CI watch — Atom
- Lauric Acid CI watch — JSON
- Lauric Acid alone — RSS
- Whole dodecanoic acid class — RSS
Cite this brief
Drug Landscape (2026). Lauric Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/dodecanoic-acid. Accessed 2026-05-15.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab